About this Research Topic
Upon receiving various danger signals, or in diseases, inflammasomes are oligomerized to form a high-molecular-weight inflammasome complex, in which procaspase-1 is converted to its active form, caspase-1. Activation of caspase-1 leads to tissue inflammation via the production of various inflammatory cytokines including interleukin 1β (IL1β) and interleukin 18 (IL18), or danger molecules such as HMGB1 (high molecular weight group box 1). These canonical cytokine and inflammatory cell-mediated inflammatory responses can cause or exacerbate the tissue inflammation and injury, contributing to the development of various degenerative and fibrotic diseases.
Moreover, recent studies showed that instigation of inflammasomes may exert non-canonical actions that directly cause cell dysfunction or injury independent of actions mediated by inflammatory cytokines. This growing list of non-canonical actions includes pyroptosis (a specific form of cell death that combines characteristics of apoptotic and necrotic death pathways), lipid handling, cytoskeleton rearrangement, intercellular junction protein regulation, or direct regulation of protein synthesis, metabolism, or secretion. In this regard, it is imperative to know the precise roles and regulatory molecular mechanisms of Nlrp3 inflammasomes in various tissue injury and fibrogenic diseases, which may provide clinical implications in developing pharmacological interventions targeting these inflammasomes.
This Research Topic will welcome original research as well as review articles to discuss all molecular aspects of inflammasomes in tissue injury and fibrosis that relate to the following topics:
-Novel danger associated molecular patterns (DAMPs) that sense inflammasomes.
-Molecular mechanisms triggering activation of inflammasomes.
-Signalling pathways that upregulates or downregulate inflammasome components.
-The novel functions of caspase-1 and their substrates beyond IL1β and IL18.
-Therapeutic potential of targeting inflammasomes.
Keywords: Inflammasome, inflammation, tissue injury, fibrosis, Nlrp3
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.